Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-03-008963
Filing Date
2003-07-29
Accepted
2003-07-29 06:05:46
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. g83827e10vk.txt 10-K 621483
3 SUBSIDIARIES g83827exv21w1.txt EX-21.1 1179
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP g83827exv23w1.txt EX-23.1 671
5 CERTIFICATE OF CEO g83827exv99w1.txt EX-99.1 1217
6 CERTIFICATE OF CFO g83827exv99w2.txt EX-99.2 1104
  Complete submission text file 0000950144-03-008963.txt   627628
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 03807100
SIC: 2834 Pharmaceutical Preparations